Simmons Bank Raises Holdings in Intuitive Surgical, Inc. $ISRG

Simmons Bank boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 15,711 shares of the medical equipment provider’s stock after buying an additional 401 shares during the quarter. Simmons Bank’s holdings in Intuitive Surgical were worth $8,538,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of ISRG. Chilton Capital Management LLC grew its holdings in Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 43 shares during the last quarter. TD Capital Management LLC grew its holdings in Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 45 shares during the last quarter. 1248 Management LLC purchased a new position in Intuitive Surgical in the first quarter worth $30,000. Princeton Global Asset Management LLC purchased a new position in Intuitive Surgical in the second quarter worth $30,000. Finally, Bank of Jackson Hole Trust grew its holdings in Intuitive Surgical by 70.5% in the first quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock worth $37,000 after purchasing an additional 31 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

ISRG has been the topic of several analyst reports. The Goldman Sachs Group lifted their price target on shares of Intuitive Surgical from $567.00 to $621.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $685.00 price target on shares of Intuitive Surgical in a report on Tuesday, October 21st. Zacks Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Friday, October 24th. Argus lifted their price target on shares of Intuitive Surgical from $600.00 to $630.00 in a report on Monday, October 27th. Finally, Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Sunday, October 26th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $608.92.

Insider Activity at Intuitive Surgical

In related news, Director Craig H. Barratt sold 2,193 shares of the business’s stock in a transaction on Friday, October 24th. The shares were sold at an average price of $548.01, for a total transaction of $1,201,785.93. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Amy L. Ladd sold 336 shares of the business’s stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the transaction, the director owned 1,074 shares of the company’s stock, valued at $504,898.14. This represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 96,011 shares of company stock valued at $50,309,042 over the last ninety days. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Down 1.0%

NASDAQ:ISRG opened at $538.82 on Wednesday. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The firm has a fifty day simple moving average of $467.13 and a 200-day simple moving average of $499.56. The company has a market capitalization of $193.15 billion, a P/E ratio of 71.27, a PEG ratio of 4.94 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same period in the previous year, the firm posted $1.84 earnings per share. The business’s revenue for the quarter was up 22.9% compared to the same quarter last year. Equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.